codon optimization algorithm (GenScript corporation)
90
Structured Review
GenScript corporation
codon optimization algorithm
Codon Optimization Algorithm, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/codon+optimization+algorithm/codon+optimization/pm40156867-399-14-13
Average 90 stars, based on 1 article reviews
Codon Optimization Algorithm, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/codon+optimization+algorithm/codon+optimization/pm40156867-399-14-13
Average 90 stars, based on 1 article reviews
codon optimization algorithm - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Gene Expression:Article Title: Recombinant receptor-binding motif of spike COVID-19 vaccine candidate induces SARS-CoV-2 neutralizing antibody response Article Snippet: To optimize this nucleotide sequence for expression in E. coli , we employed the Genscript Optimization Gene TM algorithm server. .. The Genscript Sequencing:Article Title: β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice. Article Snippet: Beta-sarcoglycan gene construction The full-length human beta-sarcoglycan cDNA (GenBank Accession No. NM_0034994.3) was codon optimized and synthesized by GenScript Inc, Piscataway, NJ, USA. .. Article Title: Method of fracturing using alkaliphile derived enzyme breaker Article Snippet: .. To prepare the enzyme breaker of the present invention, the gene structure coding for the β-mannanase enzyme isolated by Ma et al. was reengineered to remove the portion coding for the protein signal sequence in an attempt to produce a gene product with more stability, activity and yield than its wild type precursor isolated by Ma et al. Additionally, the gene sequence was codon optimized for expression in E. coli using Article Title: Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T cells in the Presence of Rituximab Article Snippet: The Fc spacer region of this construct was modified to abrogate binding to Fcγ receptors by substituting the IgG1 hinge linker with the IgG2 hinge linker and adding an N297Q mutation as previously described ( 34 , 35 ), to create the 1F5-NQ-28-BB-z vector (GenBank accession # {"type":"entrez-nucleotide","attrs":{"text":"KX055830","term_id":"1032530218","term_text":"KX055830"}} KX055830 ). .. To generate the 1.5.3-NQ-28-BB-z CAR construct, a novel scFv sequence was produced by synthesizing the V L and V H sequences from the 1.5.3 fully human anti-CD20 Ab( 36 ) (patent WO 2006/130458) using a Expressing:Article Title: β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice. Article Snippet: Beta-sarcoglycan gene construction The full-length human beta-sarcoglycan cDNA (GenBank Accession No. NM_0034994.3) was codon optimized and synthesized by GenScript Inc, Piscataway, NJ, USA. .. Article Title: Development of an Adenovirus-Based Respiratory Syncytial Virus Vaccine: Preclinical Evaluation of Efficacy, Immunogenicity, and Enhanced Disease in a Cotton Rat Model Article Snippet: .. The RSV recombinant A2cp F (rA2cp F) gene (GenBank accession no. {"type":"entrez-protein","attrs":{"text":"AAC14902.1","term_id":"3089380","term_text":"AAC14902.1"}} AAC14902.1 ) was codon optimized for optimal expression in mammalian cells by the Article Title: Method of fracturing using alkaliphile derived enzyme breaker Article Snippet: .. To prepare the enzyme breaker of the present invention, the gene structure coding for the β-mannanase enzyme isolated by Ma et al. was reengineered to remove the portion coding for the protein signal sequence in an attempt to produce a gene product with more stability, activity and yield than its wild type precursor isolated by Ma et al. Additionally, the gene sequence was codon optimized for expression in E. coli using Recombinant:Article Title: Development of an Adenovirus-Based Respiratory Syncytial Virus Vaccine: Preclinical Evaluation of Efficacy, Immunogenicity, and Enhanced Disease in a Cotton Rat Model Article Snippet: .. The RSV recombinant A2cp F (rA2cp F) gene (GenBank accession no. {"type":"entrez-protein","attrs":{"text":"AAC14902.1","term_id":"3089380","term_text":"AAC14902.1"}} AAC14902.1 ) was codon optimized for optimal expression in mammalian cells by the Synthesized:Article Title: Development of an Adenovirus-Based Respiratory Syncytial Virus Vaccine: Preclinical Evaluation of Efficacy, Immunogenicity, and Enhanced Disease in a Cotton Rat Model Article Snippet: .. The RSV recombinant A2cp F (rA2cp F) gene (GenBank accession no. {"type":"entrez-protein","attrs":{"text":"AAC14902.1","term_id":"3089380","term_text":"AAC14902.1"}} AAC14902.1 ) was codon optimized for optimal expression in mammalian cells by the Generated:Article Title: Development of an Adenovirus-Based Respiratory Syncytial Virus Vaccine: Preclinical Evaluation of Efficacy, Immunogenicity, and Enhanced Disease in a Cotton Rat Model Article Snippet: .. The RSV recombinant A2cp F (rA2cp F) gene (GenBank accession no. {"type":"entrez-protein","attrs":{"text":"AAC14902.1","term_id":"3089380","term_text":"AAC14902.1"}} AAC14902.1 ) was codon optimized for optimal expression in mammalian cells by the Subcloning:Article Title: Development of an Adenovirus-Based Respiratory Syncytial Virus Vaccine: Preclinical Evaluation of Efficacy, Immunogenicity, and Enhanced Disease in a Cotton Rat Model Article Snippet: .. The RSV recombinant A2cp F (rA2cp F) gene (GenBank accession no. {"type":"entrez-protein","attrs":{"text":"AAC14902.1","term_id":"3089380","term_text":"AAC14902.1"}} AAC14902.1 ) was codon optimized for optimal expression in mammalian cells by the Plasmid Preparation:Article Title: Development of an Adenovirus-Based Respiratory Syncytial Virus Vaccine: Preclinical Evaluation of Efficacy, Immunogenicity, and Enhanced Disease in a Cotton Rat Model Article Snippet: .. The RSV recombinant A2cp F (rA2cp F) gene (GenBank accession no. {"type":"entrez-protein","attrs":{"text":"AAC14902.1","term_id":"3089380","term_text":"AAC14902.1"}} AAC14902.1 ) was codon optimized for optimal expression in mammalian cells by the Produced:Article Title: A deep learning model trained on expressed transcripts across different tissue types reveals cell-type codon-optimization preferences. Article Snippet: .. The sequences optimized using DL models displayed significant differences from sequences produced by GenScript’s Article Title: Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab Article Snippet: The Fc spacer region of this construct was modified to abrogate binding to Fcg receptors by substituting the IgG1 hinge linker with the IgG2 hinge linker and adding anN297Qmutation as previously described (34, 35), to create the 1F5-NQ-28-BB-z vector (GenBank accession # KX055830). .. To generate the 1.5.3-NQ-28-BB-z CAR construct, a novel scFv sequencewas produced by synthesizing theVL andVH sequences from the 1.5.3 fully human anti-CD20 Ab (patent WO 2006/130458; ref. 36) using a Article Title: Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T cells in the Presence of Rituximab Article Snippet: The Fc spacer region of this construct was modified to abrogate binding to Fcγ receptors by substituting the IgG1 hinge linker with the IgG2 hinge linker and adding an N297Q mutation as previously described ( 34 , 35 ), to create the 1F5-NQ-28-BB-z vector (GenBank accession # {"type":"entrez-nucleotide","attrs":{"text":"KX055830","term_id":"1032530218","term_text":"KX055830"}} KX055830 ). .. To generate the 1.5.3-NQ-28-BB-z CAR construct, a novel scFv sequence was produced by synthesizing the V L and V H sequences from the 1.5.3 fully human anti-CD20 Ab( 36 ) (patent WO 2006/130458) using a Isolation:Article Title: Method of fracturing using alkaliphile derived enzyme breaker Article Snippet: .. To prepare the enzyme breaker of the present invention, the gene structure coding for the β-mannanase enzyme isolated by Ma et al. was reengineered to remove the portion coding for the protein signal sequence in an attempt to produce a gene product with more stability, activity and yield than its wild type precursor isolated by Ma et al. Additionally, the gene sequence was codon optimized for expression in E. coli using Activity Assay:Article Title: Method of fracturing using alkaliphile derived enzyme breaker Article Snippet: .. To prepare the enzyme breaker of the present invention, the gene structure coding for the β-mannanase enzyme isolated by Ma et al. was reengineered to remove the portion coding for the protein signal sequence in an attempt to produce a gene product with more stability, activity and yield than its wild type precursor isolated by Ma et al. Additionally, the gene sequence was codon optimized for expression in E. coli using Construct:Article Title: Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab Article Snippet: The Fc spacer region of this construct was modified to abrogate binding to Fcg receptors by substituting the IgG1 hinge linker with the IgG2 hinge linker and adding anN297Qmutation as previously described (34, 35), to create the 1F5-NQ-28-BB-z vector (GenBank accession # KX055830). .. To generate the 1.5.3-NQ-28-BB-z CAR construct, a novel scFv sequencewas produced by synthesizing theVL andVH sequences from the 1.5.3 fully human anti-CD20 Ab (patent WO 2006/130458; ref. 36) using a Article Title: Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T cells in the Presence of Rituximab Article Snippet: The Fc spacer region of this construct was modified to abrogate binding to Fcγ receptors by substituting the IgG1 hinge linker with the IgG2 hinge linker and adding an N297Q mutation as previously described ( 34 , 35 ), to create the 1F5-NQ-28-BB-z vector (GenBank accession # {"type":"entrez-nucleotide","attrs":{"text":"KX055830","term_id":"1032530218","term_text":"KX055830"}} KX055830 ). .. To generate the 1.5.3-NQ-28-BB-z CAR construct, a novel scFv sequence was produced by synthesizing the V L and V H sequences from the 1.5.3 fully human anti-CD20 Ab( 36 ) (patent WO 2006/130458) using a |
